C40.82
C40.82 — Malignant neoplasm of overlapping sites of bone and articular cartilage of left limb
Billable / specific codeICD-10-CMleft
C40.82 is a billable, specific ICD-10-CM code for malignant neoplasm of overlapping sites of bone and articular cartilage of left limb. It is valid for submission on a claim.
Risk adjustment
C40.82 risk-adjusts. Under the CMS-HCC V28 model it maps to this category:
- HCC 21 Lymphoma and Other Cancers0.671 RAF
Coefficient shown for the Community Non-dual Aged segment. A higher HCC in the same hierarchy will suppress this one, so capturing it does not always add score.
Medicare coverage
C40.82 is named in 60 Medicare coverage policies — 60 listing it as supporting medical necessity. Which of them applies to you depends on your Medicare contractor, and coverage genuinely differs by state.
- A52399Billing and Coding: Denosumab (Prolia®, Xgeva®, Jubbonti®, Wyost®, Ospomyv™,Xbryk™,Bomyntra®, Conexxence®, Stoboclo®, Osenvelt®,Bildyos®, Bilprevda®)
- A52479Oral Anticancer Drugs - Policy Article
- A52479Oral Anticancer Drugs - Policy Article
- A52479Oral Anticancer Drugs - Policy Article
Related codes at this level
Codes that share C40.8. If C40.82 is not quite right, the correct code is usually one of these.
Questions about C40.82
- Is C40.82 a billable ICD-10-CM code?
- Yes. C40.82 is a billable, specific ICD-10-CM code and is valid for submission on a claim.
- Where does C40.82 sit in the tabular list?
- Neoplasms (C00-D49), in the block Malignant neoplasms of bone and articular cartilage (C40-C41).